sUMMARY Metoprolol (200 mg daily) and propranolol (160 mg daily) were each given for one week to 11 normal subjects. The order of administration was randomised and not known to us during the study. Each period of treatment with active drug was followed by one week during which placebo tablets were taken.
Beta-adrenergic blocking agents have measurable effects on haemodynamic, angiocardiographic, and echocardiographic indices of left ventricular function. We have used echocardiography to make repeated measurements of left ventricular dimensions and contractility and of cardiac output and systemic vascular resistance during a crossover trial of metoprolol and propranolol, and compared the effects of these agents and their duration after stopping each drug.
Methods
The subjects were normal volunteers who gave their informed consent. They were between 21 and 29 years of age, and were selected because we were able to record left ventricular echocardiograms of high quality. After baseline studies each subject took either propranolol (80 mg bd orally) or metoprolol (100 mg bd orally) for one week (weeks 1 and 3). The order of administration was randomised and matching placebo was used throughout. During weeks 2 and 4 placebo only was given. The drugs were packaged in Dosetts, a weekly tablet dispensing system. The procedure is summarised in Echocardiograms were recorded before admission to the trial, twice during each phase of active
Received for publication 8 March 1979 drug administration, and daily for three days and on the seventh day after the drugs were stopped. Both drugs produced significant reductions in heart rate, mean blood pressure, and cardiac output. With propranolol the heart rate and blood pressure reductions were still significant the day after the drug was stopped. Propranolol administration resulted in reduction in left ventricular diastolic dimension and diastolic dD/dtmax, and with an increase in the systemic vascular resistance (Table) . When the drugs were compared, mean values for diastolic dimension and cardiac output were greater with metoprolol, while diastolic dD/dtmax, mean blood pressure, and peripheral resistance were less. (n = 10) (n = 10) (n = 10) (n = 10) (n = 10) (n = 10) (n = 10) (n = 10) (n= 10) (n = 10) (n = 10) (n=9) (n=9) (n = 10) (n= 10) (n= 10) (n = 10) Our normal values for systolic and diastolic dD/ dtmax were similar to those reported by Gibson and Brown, 15 and Paoloni et al.16 and were not affected materially by smoothing and averaging during computer analysis. We compared recordings made at 50 mm/s and at 100 mm/s using as a model two sine waves with a 900 phase difference, and found no significant differences in the derived "dimensions" and rates of change of "wall motion". We were concerned about differences from cycle to cycle and from day to day, and particularly about the fairly large variations in peak rates of change of dimension noted by Bass and Whitlock."7 In other studies we have analysed up to 50 successive cycles in normal subjects with sinus arrhythmia, and found that dimensions varied by as much as 10 per cent and peak rates of change by up to 25 per cent. For this reason we measured at least five cycles and used only recordings of high quality for calculating rates of change of dimension.
It seems to us that this difficulty in obtaining representative measurements of ventricular dimensions and wall motion must apply also to angiocardiographic techniques. There is no information on the beat-to-beat variation which may occur in radiological studies. Echocardiography had the great advantage of allowing us to obtain a much larger sample on any one occasion and to obtain repeated measurements under comparable conditions. Fig. 3 tendency for propranolol to produce greater falls in heart rate and cardiac output, and significant increases in the systemic vascular resistance. There is a fairly large scatter in the values for cardiac output and systemic resistance which could have been reduced if these had been "corrected" for body surface area, but as the subjects were compared with themselves the levels of significance would not have been altered. Fig. 4 well as heart rate and blood pressure, and that these effects could be reversed with atropine and phenylephrine. We were not able to show that either drug produced any significant change in indices of left ventricular systolic function (fractional shortening, peak Vcf, or systolic dD/dtmax), though the negative correlation between these indices and systemic vascular resistance suggests either that they are responsive to changes in afterload or that (like heart rate) they are directly affected by beta-adrenergic blocking agents. In any case the net effect is reduction in blood pressure resulting from a fall in cardiac output which is itself largely rate dependent.
Although it would be difficult to show that metoprolol should be preferred to propranolol in clinical practice, except for patients with asthma, the different effects of these and other betaadrenergic blocking agents on peripheral vascular resistance at rest or during exercise or the infusion of catecholamines deserve further investigation. Despite its limitations M-mode echocardiography is a most attractive tool for studies of this kind. 
